Literature DB >> 19849715

Mouse models for melanoma: a personal perspective.

Jürgen C Becker1, Roland Houben, David Schrama, Heike Voigt, Selma Ugurel, Ralph A Reisfeld.   

Abstract

Complex biological processes often require in vivo analysis, and many important research advances have been made using mice as a model for the study of various biological systems. Cutaneous melanomas are tumors originating from skin melanocytes, which are present in hair follicles, and interfollicular epidermal and dermal layers. Until recently, mouse melanoma models were largely based on transplantation models, i.e. transplantation of either syngeneic or xenogeneic melanoma cells into wild type or genetically modified animals. More recently, however, the use of novel technologies specifically modifying the genome allows for the generation of mouse strains, which may develop spontaneous melanoma. Nevertheless, it should be kept in mind that animal models provide only an approximation of reality in humans. In this review, we will discuss a representative selection of currently available transplantation and transgenic melanoma models; despite the fact that this selection will be biased by personal experience, we are confident to demonstrate how the use of mouse melanoma models facilitates translational research in several biomedical disciplines.

Entities:  

Mesh:

Year:  2009        PMID: 19849715     DOI: 10.1111/j.1600-0625.2009.00986.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  29 in total

1.  Role of TRPM in melanocytes and melanoma.

Authors:  Huazhang Guo; John Andrew Carlson; Andrzej Slominski
Journal:  Exp Dermatol       Date:  2012-09       Impact factor: 3.960

Review 2.  Melanocytes, melanocyte stem cells, and melanoma stem cells.

Authors:  Deborah Lang; Joseph B Mascarenhas; Christopher R Shea
Journal:  Clin Dermatol       Date:  2013 Mar-Apr       Impact factor: 3.541

Review 3.  Animal models of skin disease for drug discovery.

Authors:  Pinar Avci; Magesh Sadasivam; Asheesh Gupta; Wanessa Cma De Melo; Ying-Ying Huang; Rui Yin; Rakkiyappan Chandran; Raj Kumar; Ayodeji Otufowora; Theodore Nyame; Michael R Hamblin
Journal:  Expert Opin Drug Discov       Date:  2013-01-08       Impact factor: 6.098

Review 4.  Model Systems for the Study of Malignant Melanoma.

Authors:  Randal K Gregg
Journal:  Methods Mol Biol       Date:  2021

5.  Synergy of brief activation of CD8 T-cells in the presence of IL-12 and adoptive transfer into lymphopenic hosts promotes tumor clearance and anti-tumor memory.

Authors:  C Marcela Díaz-Montero; Osama Naga; Abdel-Aziz A Zidan; Mohamed L Salem; Maria Pallin; Anita Parmigiani; Gail Walker; Eric Wieder; Krishna Komanduri; David J Cole; Alberto J Montero; Mathias G Lichtenheld
Journal:  Am J Cancer Res       Date:  2011-08-30       Impact factor: 6.166

6.  In vivo screening of S100B inhibitors for melanoma therapy.

Authors:  Danna B Zimmer; Rena G Lapidus; David J Weber
Journal:  Methods Mol Biol       Date:  2013

7.  UV-induced somatic mutations elicit a functional T cell response in the YUMMER1.7 mouse melanoma model.

Authors:  Jake Wang; Curtis J Perry; Katrina Meeth; Durga Thakral; William Damsky; Goran Micevic; Susan Kaech; Kim Blenman; Marcus Bosenberg
Journal:  Pigment Cell Melanoma Res       Date:  2017-06-08       Impact factor: 4.693

Review 8.  A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme.

Authors:  Kenneth E Bernstein; Frank S Ong; Wendell-Lamar B Blackwell; Kandarp H Shah; Jorge F Giani; Romer A Gonzalez-Villalobos; Xiao Z Shen; Sebastien Fuchs; Rhian M Touyz
Journal:  Pharmacol Rev       Date:  2012-12-20       Impact factor: 25.468

9.  Alphavirus replicon particles expressing TRP-2 provide potent therapeutic effect on melanoma through activation of humoral and cellular immunity.

Authors:  Francesca Avogadri; Taha Merghoub; Maureen F Maughan; Daniel Hirschhorn-Cymerman; John Morris; Erika Ritter; Robert Olmsted; Alan N Houghton; Jedd D Wolchok
Journal:  PLoS One       Date:  2010-09-10       Impact factor: 3.240

10.  Injectable cryogel-based whole-cell cancer vaccines.

Authors:  Sidi A Bencherif; R Warren Sands; Omar A Ali; Weiwei A Li; Sarah A Lewin; Thomas M Braschler; Ting-Yu Shih; Catia S Verbeke; Deen Bhatta; Glenn Dranoff; David J Mooney
Journal:  Nat Commun       Date:  2015-08-12       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.